US Edition
News from Globe Newswire
If you want to know if Globe Newswire is credible or reliable, look no further. We rank Globe Newswire as High factuality. Find out more about our methodology here.
Information about Globe Newswire
Where is Globe Newswire located?Globe Newswire's WebsiteGlobe Newswire's TwitterGlobe Newswire's WikipediaMedia Bias Ratings
Average Bias Rating:
Center
Center
byMedia Bias/Fact CheckDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Globe Newswire News
Microsoft · United StatesMicrosoft has struck a deal with data-center operator IREN that includes access to Nvidia's advanced chips, aiming to ease the computing crunch that has kept the tech giant from fully cashing in on the artificial intelligence boom.See the Story
Microsoft Signs $9.7 Billion AI Cloud Deal With Australia’s IREN
68% Center coverage: 51 sources
Business · United KingdomBritain’s antitrust watchdog said Monday that it is escalating its investigation of plans by Getty Images to buy rival Shutterstock, stepping up scrutiny of the $3.7 billion deal that would create a visual content giant.See the Story
Getty’s $3.7 billion attempt to buy Shutterstock faces in-depth investigation in the UK
Coverage: 14 sources
FDA · United States(MedPage Today) -- The FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare mitochondrial depletion syndrome, the agency announced on Monday.
A pair of pyrimidine nucleosides, the doxecitine...See the Story
Ultra-Rare Mitochondrial Disease Gets First FDA-Approved Drug
46% Right coverage: 11 sources
